Drugs / Hyperpolarized [2-13C] Pyruvate
Hyperpolarized [2-13C] Pyruvate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03502967 | Jun 2018 → Jun 2026 overdue | traumatic brain injury | University of Texas Southwestern Medical Center | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hyperpolarized [2-13C] Pyruvate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03502967 ↗ |
| Modality | Diagnostic / imaging agent | “hyperpolarized 13C-pyruvate as imaging agents” NCT03502967 ↗ |
| Route | Other | “Bolus injection of study drug” NCT03502967 ↗ |